ROCreceiver operating characteristic – Communicable Diseases Research

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry

Research article

Published on 2022-08-012022-10-05
Journal: Thrombosis research [Category] COVID19(2023년), SARS, 바이오마커,

[키워드] abnormality Accuracy Acute kidney injury acute respiratory distress syndrome adjusted Admission AKIAcute Kidney Injury Analysis ARDSacute respiratory distress syndrome area under the curve assessment AUCarea under the curve BNPbrain natriuretic peptide brain natriuretic peptide C-reactive protein cardiovascular disease cardiovascular disease risk factor chest X-ray Coagulation coefficient cohort study confidence interval coronavirus disease-2019 COVID-19 patient COVID-19coronavirus disease-2019 CRPC-reactive protein CVDRFcardiovascular disease risk factor D-dimer D-dimer level Deep vein thrombosis develop DVTdeep vein thrombosis embolic event Factor Hospitalization hospitalized patient identify In-hospital in-hospital mortality Invasive mechanical ventilation Japanese lactate dehydrogenase LASSOleast absolute shrinkage and selection operator LDHlactate dehydrogenase least absolute shrinkage and selection operator limitation Male sex N-terminal prohormone of brain natriuretic peptide NT-pro-BNPN-terminal prohormone of brain natriuretic peptide Occurrence operator parameter Patient patients with COVID-19 potential risk Predictive Predictive model PTEpulmonary thromboembolism Pulmonary thromboembolism receiver operating characteristic reducing Registered registry reported Result risk risk factor ROCreceiver operating characteristic shown significantly Support the primary endpoint thromboembolic Thromboembolic events Thromboembolism Venous Thromboembolism VTEVenous Thromboembolism was performed WBCWhite blood cell White blood cell with COVID-19
[DOI] 10.1016/j.thromres.2022.06.007 [Article Type] Research article

MALDI-ToF protein profiling as a potential rapid diagnostic platform for COVID-19

Research article

Published on 2021-08-012022-10-05
Journal: Journal of Mass Spectrometry and Advances in the Clinical Lab [Category] 바이오마커, 변종, 진단,

[키워드] liquid chromatography mass spectrometry ACE2angiotensin-converting enzyme 2 Analysis analyzed angiotensin-converting enzyme 2 area under the curve Asymptomatic AUCarea under the curve Biomarker Cohort Concordance controls Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 testing COVID-19coronavirus disease 2019 CT cycle threshold demonstrated develop diagnostic Diagnostic method dithiothreitol DTTdithiothreitol E Proteinenvelope protein Emergency use authorization envelope protein EUAemergency use authorization FDAFood and Drug Administration Food and Drug Administration human donor human serum IgAimmunoglobulin A IgGimmunoglobulin G IgMimmunoglobulin M immunoglobulin A Immunoglobulin G immunoglobulin M immunoglobulins inactivated LC-MS limit of detection limitation LoDlimit of detection M Proteinmembrane protein MALDI-ToF MSmatrix-assisted laser desorption/ionization-time of flight mass spectrometry matrix-assisted laser desorption/ionization-time of flight mass spectrometry membrane protein N Proteinnucleocapsid protein nasopharyngeal Nasopharyngeal swab nasopharyngeal swabs Non-invasive NPnasopharyngeal nucleocapsid protein pilot study platform positive individuals Protein proteome RBDReceptor Binding Domain receiver operating characteristic Receptor binding domain Reverse transcriptase quantitative polymerase chain reaction Ribonucleic acid RNARibonucleic acid ROCreceiver operating characteristic RT-qPCR S Proteinspike protein Saliva SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 virus SARS-CoV-2severe acute respiratory syndrome coronavirus 2 sensitivity severe acute respiratory syndrome coronavirus 2 specificity specimen Spike protein VEPviral envelope protein viral envelope protein WHOWorld Health Organization with COVID-19 World Health Organization
[DOI] 10.1016/j.jmsacl.2021.09.001 [Article Type] Research article